I have just spoken to the secretary at Axon and he said that at this date they have US$35,000,000 in cash and bonds, and the stem cell problem should have no effect on Axon, if anything it would be a plus for Axon.RegardsWestcott.
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
